Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $113,225 | 61 | 61.0% |
| Honoraria | $27,150 | 17 | 14.6% |
| Travel and Lodging | $22,365 | 96 | 12.1% |
| Food and Beverage | $10,217 | 262 | 5.5% |
| Consulting Fee | $6,000 | 2 | 3.2% |
| Education | $3,519 | 3 | 1.9% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $3,000 | 1 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $63,220 | 140 | $0 (2020) |
| ABBVIE INC. | $48,514 | 72 | $0 (2024) |
| QOL Medical, LLC | $47,146 | 79 | $0 (2024) |
| Boston Scientific Corporation | $13,865 | 82 | $0 (2024) |
| Wilson Cook Medical Incorporated | $10,411 | 18 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $456.83 | 5 | $0 (2019) |
| Cook Medical LLC | $251.09 | 4 | $0 (2019) |
| PFIZER INC. | $215.46 | 2 | $0 (2019) |
| FUJIFILM Healthcare Americas Corporation | $193.37 | 1 | $0 (2024) |
| GENZYME CORPORATION | $162.34 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $31,873 | 70 | QOL Medical, LLC ($26,367) |
| 2023 | $20,998 | 40 | QOL Medical, LLC ($20,656) |
| 2022 | $7,271 | 26 | ABBVIE INC. ($6,792) |
| 2021 | $10,373 | 12 | AbbVie Inc. ($10,222) |
| 2020 | $5,723 | 5 | AbbVie Inc. ($3,085) |
| 2019 | $12,085 | 59 | Wilson Cook Medical Incorporated ($3,519) |
| 2018 | $54,617 | 111 | Allergan Inc. ($31,844) |
| 2017 | $42,536 | 119 | Allergan Inc. ($25,438) |
All Payment Transactions
442 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | QOL Medical, LLC | SUCRAID (Drug) | Honoraria | Cash or cash equivalent | $1,500.00 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | QOL Medical, LLC | SUCRAID (Drug) | Honoraria | Cash or cash equivalent | $3,600.00 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/12/2024 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/12/2024 | QOL Medical, LLC | SUCRAID (Drug) | Honoraria | Cash or cash equivalent | $750.00 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/12/2024 | QOL Medical, LLC | SUCRAID (Drug) | Honoraria | Cash or cash equivalent | $375.00 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/12/2024 | QOL Medical, LLC | SUCRAID (Drug) | Travel and Lodging | Cash or cash equivalent | $304.78 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/12/2024 | QOL Medical, LLC | SUCRAID (Drug) | Travel and Lodging | Cash or cash equivalent | $70.00 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/12/2024 | QOL Medical, LLC | SUCRAID (Drug) | Travel and Lodging | Cash or cash equivalent | $22.00 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/12/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $19.44 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/11/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $28.09 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | QOL Medical, LLC | SUCRAID (Drug) | Travel and Lodging | Cash or cash equivalent | $624.20 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/23/2024 | QOL Medical, LLC | SUCRAID (Drug) | Travel and Lodging | Cash or cash equivalent | $521.94 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/23/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $123.06 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $116.97 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: IMMUNOLOGY | ||||||
| 10/01/2024 | QOL Medical, LLC | SUCRAID (Drug) | Honoraria | Cash or cash equivalent | $375.00 | General |
| Category: THERAPY FOR CSID | ||||||
| 09/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: Immunology | ||||||
| 09/24/2024 | QOL Medical, LLC | SUCRAID (Drug) | Honoraria | Cash or cash equivalent | $1,500.00 | General |
| Category: THERAPY FOR CSID | ||||||
| 09/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $0.26 | General |
| Category: IMMUNOLOGY | ||||||
| 09/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 562 | 581 | $445,914 | $66,460 |
| 2022 | 17 | 611 | 638 | $480,082 | $69,730 |
| 2021 | 22 | 716 | 919 | $508,063 | $76,674 |
| 2020 | 20 | 783 | 1,011 | $460,907 | $76,045 |
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 105 | 105 | $136,605 | $20,977 | 15.4% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2023 | 18 | 21 | $24,885 | $6,649 | 26.7% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 43 | 44 | $34,540 | $6,219 | 18.0% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 26 | 27 | $29,511 | $4,831 | 16.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 84 | 87 | $72,993 | $4,295 | 5.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 68 | $11,016 | $3,845 | 34.9% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 19 | 19 | $25,308 | $3,542 | 14.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $10,584 | $3,397 | 32.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 24 | $7,944 | $2,406 | 30.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 24 | $5,928 | $2,131 | 36.0% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2023 | 17 | 17 | $9,554 | $1,910 | 20.0% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 17 | 18 | $8,172 | $1,754 | 21.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 31 | 31 | $36,983 | $1,586 | 4.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 23 | $4,255 | $1,401 | 32.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $9,412 | $1,025 | 10.9% |
| 43262 | Incision of pancreatic outlet using a flexible endoscope | Facility | 2023 | 16 | 16 | $17,744 | $424.96 | 2.4% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 16 | 16 | $480.00 | $68.17 | 14.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 114 | 114 | $148,289 | $22,400 | 15.1% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 44 | 47 | $36,892 | $6,510 | 17.6% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 30 | 31 | $33,877 | $5,766 | 17.0% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2022 | 15 | 17 | $20,145 | $5,644 | 28.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 69 | 82 | $13,270 | $5,068 | 38.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 90 | 91 | $76,336 | $4,313 | 5.6% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2022 | 18 | 19 | $25,302 | $3,395 | 13.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $11,709 | $3,384 | 28.9% |
About Dr. David Lo, M.D
Dr. David Lo, M.D is a Internal Medicine healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720161854.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Lo, M.D has received a total of $185,475 in payments from pharmaceutical and medical device companies, with $31,873 received in 2024. These payments were reported across 442 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($113,225).
As a Medicare-enrolled provider, Lo has provided services to 2,672 Medicare beneficiaries, totaling 3,149 services with total Medicare billing of $288,909. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology, Gastroenterology
- Location Columbus, OH
- Active Since 10/23/2006
- Last Updated 11/07/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1720161854
Products in Payments
- LINZESS (Drug) $66,821
- SUCRAID (Drug) $26,490
- CREON (Drug) $20,753
- Creon (Drug) $20,663
- Sucraid (Drug) $20,656
- Cook Medical Biliary (Device) $5,724
- COOK MEDICAL BILIARY (Device) $4,109
- GENERAL BILIARY DEVICES (Device) $3,603
- GENERAL - THERAPIES (Device) $3,111
- GENERAL - BILIARY DEVICES (Device) $2,364
- THERAPIES (Device) $1,208
- GENERAL PULMONARY (Device) $729.25
- Cook Medical Endoscopic Ultrasound (Device) $725.27
- EXPECT (Device) $655.64
- AXIOS (Device) $340.28
- SPYGLASS (Device) $336.10
- ACQUIRE (Device) $274.12
- RINVOQ (Biological) $264.68
- XIFAXAN (Drug) $261.48
- Humira (Biological) $251.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Columbus
Anish Amin, M.d, M.D
Internal Medicine — Payments: $807,022
Dr. Alexa Meara, Md, MD
Internal Medicine — Payments: $377,655
Jayanta Mukherjee, Md, MD
Internal Medicine — Payments: $240,062
Narendranath Epperla, Md, MD
Internal Medicine — Payments: $184,240
Lucy Laperna, Do, DO
Internal Medicine — Payments: $133,632
Carlos Malvestutto, M.d, M.D
Internal Medicine — Payments: $107,580